Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Berko İlaç Ve Ki̇mya Sanayi̇ A.Ş.filedCriticalBerko İlaç Ve Ki̇mya Sanayi̇ A.Ş.
Priority to TR2011/05424ApriorityCriticalpatent/TR201105424A2/en
Publication of TR201105424A2publicationCriticalpatent/TR201105424A2/en
Mevcut buluş, çinko eksikliğinde replasman tedavisinde, akrodermatitis enteropatika, wilson hastalığının tedavisinde kullanılmaya elverişli tercihen şurup formunda etken madde olarak çinko içeren bir formülasyon ile ilgilidir.The present invention relates to a formulation containing zinc as the active ingredient in the form of syrup, preferably suitable for use in the treatment of zinc deficiency replacement, acrodermatitis enteropatica, wilson's disease.
TR2011/05424A2011-06-032011-06-03
A pharmaceutical formulation with zinc active ingredient.
TR201105424A2
(en)
APPLICATION FOR THE TREATMENT OF AKKERMANSIA MUCINIPHILA metabolic disorders, increased energy consumption and satiety, weight loss, compositions, pharmaceutical composition, a cosmetic compositions and medicaments
OPHTHALMIC COMPOSITION INCLUDING AN ANDROGEN AND ITS USE FOR THE MANUFACTURE OF A USEFUL MEDICINAL PRODUCT FOR THE TREATMENT OF AN EYE DISEASE RESULTING FROM AN ANDROGENIC DEFICIENCY
1-cyano-2- (4-cyclopropyl-benzyl) -4- (beta-d-glycopyran-1-yl) -benzene crystalline complex, methods for its preparation and use thereof to prepare medicaments
Pyrazole compounds, crth2 antagonist; pharmaceutical composition; use in the treatment of inflammatory, infectious, immunoregulatory disorders, respiratory diseases, gastrointestinal or ailments, among others.